Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review

Dalbavancin (DAL) is a lipoglycopeptide with bactericidal activity against a very wide range of Gram-positive microorganisms. It also has unique pharmacokinetic properties, namely a prolonged half-life (around 181 h), which allows a convenient weekly dosing regimen, and good diffusion in bone tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Buzón-Martín, Luis, Zollner-Schwetz, Ines, Tobudic, Selma, Cercenado, Emilia, Lora-Tamayo, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227288/
https://www.ncbi.nlm.nih.gov/pubmed/34072670
http://dx.doi.org/10.3390/antibiotics10060656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227288/
https://www.ncbi.nlm.nih.gov/pubmed/34072670
http://dx.doi.org/10.3390/antibiotics10060656

Ejemplares similares